|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Relay Therapeutics (NASDAQ: RLAY) through any online brokerage.
The latest price target for Relay Therapeutics (NASDAQ: RLAY) was reported by HC Wainwright & Co. on August 17, 2021. The analyst firm set a price target for 54.00 expecting RLAY to rise to within 12 months (a possible 74.53% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Relay Therapeutics (NASDAQ: RLAY) is $30.94 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Relay Therapeutics.
Relay Therapeutics’s $Q3 earnings are confirmed for after-market on $November 11, 2021.
There is no upcoming split for Relay Therapeutics.
Relay Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.